STOCK TITAN

Olink to report first quarter 2023 financial results on May 11, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) announced that it will release its financial results for Q1 2023 on May 11, 2023, before the market opens. Management will host a conference call at 8:00 AM ET to discuss these results. Investors wishing to participate are advised to register in advance. The company focuses on advancing proteomics in collaboration with the scientific community, impacting various disease areas to enhance patient outcomes. Established in 2016, Olink operates globally, with a robust presence in Europe, North America, and Asia.

Positive
  • Olink will release Q1 2023 financial results, providing transparency to investors.
  • The company is positioned well in the growing proteomics market, collaborating with major biopharmaceutical firms.
Negative
  • None.

UPPSALA, Sweden, April 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2023 before the market open on Thursday, May 11, 2023. Company management will host a conference call to discuss these results at 8:00 am ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live webcast of the conference call will be available in the “Events” section of the Company's website at https://investors.olink.com/investor-relations. The webcast will be archived and available for replay for at least 90 days after the event.

About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.

Investor Contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com

Media Contact
Andrea Prander
Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com


FAQ

When will Olink release its Q1 2023 financial results?

Olink will release its Q1 2023 financial results on May 11, 2023.

What time is the Olink Q1 2023 earnings call?

The earnings call for Q1 2023 will be at 8:00 AM ET on May 11, 2023.

How can investors listen to Olink's conference call?

Investors can register online to listen to the conference call, and it will also be available via a live webcast.

What is Olink's business focus?

Olink is focused on advancing proteomics to improve patient outcomes through collaborations with the scientific community.

Olink Holding AB (publ) American Depositary Shares

NASDAQ:OLK

OLK Rankings

OLK Latest News

OLK Stock Data

3.24B
41.90M
66.41%
35.24%
2.03%
Diagnostics & Research
Healthcare
Link
United States of America
Uppsala